Catherine Bresson

Director, Operational Team, WIN Consortium

Michel Ducreux

Head of the Clinical Trials Committee, WIN Consortium; Head of Digestive Oncology department, Gustave Roussy (France)

Razelle Kurzrock

Chief Medical Officer, WIN Consortium; Professor of Medicine, Associate Director, Clinical Research, Linda T. and John A. Mellowes Endowed Chair of Precision Oncology (USA)

Vladimir Lazar

Chief Scientific and Operating Officer, WIN Consortium

Yves A. Luisser

Chairman, Scientific Advisory Board, WIN Consortium; Professor and Chair, Department of Biomedical Informatics, The University of Utah School of Medicine (USA)

Amir Onn

Head of Standard Operating Procedures and Repository Committee, WIN Consortium; Chair, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)

Jacques Raynaud

Senior adviser to WIN Strategy, Science and Fundraising, WIN Consortium

Richard L. Schilsky

Chairman, WIN Consortium; Professor Emeritus, University of Chicago; past President and former Executive Vice President & Chief Medical Officer (ASCO) (USA)

Marina Sekacheva

Head of the Membership Committee, WIN Consortium; Director of Personalized Oncology Institute, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)

Josep Tabernero

Vice Chairman, WIN Consortium; Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Catherine Bresson

Director, Operational Team, WIN Consortium

Layla El-Gharras

Assistant, Operational Team, WIN Consortium

Vladimir Lazar

Chief Scientific and Operating Officer, WIN Consortium

Shai Magidi

IT Data Manager, WIN Consortium

Jacques Raynaud

Senior adviser to WIN Strategy, Science and Fundraising, WIN Consortium

Eitan Rubin

Head of Bioinformatics, WIN Consortium; Senior Lecturer, Ben-Gurion University of the Negev (Israel)

Fanny Wunder

Project Manager, WIN Consortium

Gerald Batist

Professor & Chair, Department of Oncology, McGill University and Director, Segal Cancer Centre (Canada)

Ioana Berindan-Neagoe

Scientific Director, The University of Medicine and Pharmacy Iuliu Hatieganu (Romania)

Anton Buzdin

Head of Laboratory for Clinical Genomic Bioinformatics; Head of Genomic Center; Sechenov First Moscow Medical University (Russia)

Andrea Califano

Chair of Department of Systems Biology, Columbia University (USA)

Benedito A. Carneiro

Co-Leader Cancer Therapeutics Program, Legorreta Cancer Center at Brown University (USA)

Phillip G. Febbo

Chief Medical Officer and Senior Vice President, Clinical Genomics, Illumina (USA)

Stanley R. Hamilton

Vice Chair, Scientific Advisory Board, WIN Consortium; Chair and Professor, Department of Pathology, City of Hope Comprehensive Cancer Center (USA)

Roy S. Herbst

Ensign Professor of Medicine; Chief of Medical Oncology; Deputy Director of Yale Cancer Center and Smilow Cancer Hospital (USA)

Paul Hofman

Professor of Pathology, Nice Sophia Antipolis University (France)

Pasi A. Jänne

Director, Lowe Center for Thoracic Oncology and Scientific Director, Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute (USA)

Yves A. Luisser

Chairman, Scientific Advisory Board, WIN Consortium; Professor and Chair, Department of Biomedical Informatics, The University of Utah School of Medicine (USA)

John Quackenbush

Professor, Computational Biology and Bioinformatics and Chair, Dept of Biostatistics, Harvard T.H Chan School of Public Health and Professor at Dana-Farber Cancer Institute (USA)

Gideon Rechavi

Head, Sheba Cancer Research Center, Chaim Sheba Medical Center (Israel)

Gary L. Rosner

Director of the Quantitative Sciences Program and Biostatistics/Bioinformatics Division, Department of Oncology, John Hopkins Medicine (USA)

Eytan Ruppin

Chief, Cancer Data Science Laboratory, National Institute of Health (NIH) (USA)

Lillian Siu

Senior Scientist, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre (Canada)

Yosef Yarden

Professor, Weizmann Institute of Science (Israel)

Zhen Chen

Vice President, Fudan University Shanghai Cancer Center (China)

Cristiano de Pádua Souza

Medical Oncologist, Department of Oncology, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)

Michel Ducreux

Head of the Clinical Trials Committee, WIN Consortium; Head of Digestive Oncology department, Gustave Roussy (France)

Wafik El-Deiry

Director, Legorreta Cancer Center at Brown University (USA)

Ulrik Lassen

Professor, Head of Phase 1 Unit, Rigshospitalet (Denmark)

Jean-François Martini

Senior Director, Translational Oncology, Global Product Development-Oncology, Pfizer, Inc. (USA)

Amir Onn

Head of Standard Operating Procedures and Repository Committee, WIN Consortium; Chair, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)

Prithwish Pal

Associate Director, Medical Affairs - Oncology, Illumina (USA)

Alejandro Piris

Head of the Scientific Management Department, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Angel Porgador

Professor and Dean, Faculty of Health Sciences, Ben-Gurion University of the Negev (Israel)

C.S. Pramesh

Director, Tata Memorial Hospital; Professor and Head, Thoracic Surgery, Division of Surgical Oncology, Tata Memorial Centre (India)

Eitan Rubin

Head of Bioinformatics, WIN Consortium; Senior Lecturer, Ben-Gurion University of the Negev (Israel)

Pierre Saintigny

Laboratory of Translational Research, Department of Translational Research and Innovation, Centre Léon Bérard (France)

Richard L. Schilsky

Chairman, WIN Consortium; Professor Emeritus, University of Chicago; past President and former Executive Vice President & Chief Medical Officer (ASCO) (USA)

Marina Sekacheva

Head of the Membership Committee, WIN Consortium; Director of Personalized Oncology Institute, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)

Benjamin M. Solomon

Asst Professor of Medicine, Avera Cancer Institute (USA)

Alan Spatz

Director, Department of Pathology & Professor of Pathology & Oncology, Jewish General Hospital & McGill University (Canada)

Josep Tabernero

Vice Chairman, WIN Consortium; Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Casey Williams

Chief Scientific Officer and Executive Director of Cancer Research, Avera Cancer Institute (USA)

Hikmat Abdel-Razeq

Chief Medical Officer, Chief Medical officer and Deputy Director General King Hussein Cancer Center (Jordan)

Amal Al Omari

Chief Scientific Officer, King Hussein Cancer Center (Jordan)

Fabrice André

Head of Research and Professor in Department of Medical Oncology, Gustave Roussy (France)

Gerald Batist

Professor & Chair, Department of Oncology, McGill University and Director, Segal Cancer Centre (Canada)

Guy Berchem

Head of Medical Oncology department, Centre Hospitalier de Luxembourg; Associate Medical Director, Luxembourg Institute of Health (Luxembourg)

Raanan Berger

Director, Institute of Oncology, Sheba Medical Center (Israel)

Ioana Berindan-Neagoe

Scientific Director, The University of Medicine and Pharmacy Iuliu Hatieganu (Romania)

Jean-Yves Blay

Professor of Medicine, Université Claude Bernard; Scientific Director, Canceropole Lyon Rhône Alpes, Centre Léon Bérard (France)

Rares Buiga

Head of Pathology, The Oncology Institute Ion Chiricuta (IOCN) (Romania)

Anca Dana Buzoianu

Rector, The University of Medicine and Pharmacy Iuliu Haţieganu (Romania)

David Cantú de León

Deputy Director of Clinical Research, Instituto Nacional de Cancerologia (INCan)(Mexico)

Benedito A. Carneiro

Co-Leader Cancer Therapeutics Program, Legorreta Cancer Center at Brown University (USA)

Andrés Cervantes

Scientific Director, INCLIVA (Spain)

Zhen Chen

Vice President, Fudan University Shanghai Cancer Center (China)

Francesco De Lorenzo

President, European Cancer Patient Coalition - ECPC (Belgium)

Cristiano de Pádua Souza

Medical Oncologist, Department of Oncology, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)

Michel Ducreux

Head of the Clinical Trials Committee, WIN Consortium; Head of Digestive Oncology department, Gustave Roussy (France)

François Dupré

Director General, Fondation ARC (France)

Wafik El-Deiry

Director, Legorreta Cancer Center at Brown University (USA)

Manon Gantenbein

Head of Unit CIEC & CPMO, Clinical and Epidemiological Investigation Center, Luxembourg Institute of Health (Luxembourg)

Serban Ghiorghiu

VP, R&D Clinical Excellence and Head of Clinical, Late Oncology, AstraZeneca (United Kingdom)

Sadakatsu Ikeda

Associate Professor, Deputy Director, Tokyo Medical and Dental University Cancer Center (Japan)

John Jiang

Senior Director of Global Medical Affairs for Oncology, Illumina (USA)

Anthony Joshua

Head of Department, Department of Medical Oncology, The Kinghorn Cancer Centre, St Vincent's Hospital (Australia)

Ulrik Lassen

Professor, Head of Phase 1 Unit, Rigshospitalet (Denmark)

Klaus Lindpaintner

Distinguished Scientist, InterVenn (USA)

Jia Liu

Staff Specialist Medical Oncology and Translational Lead of Phase 1 Unit, The Kinghorn Cancer Center, St Vincent's Hospital (Australia)

Juan Martín Liberal

Consultant Medical Oncologist Melanoma, Sarcoma and GU Tumors Unit Early Drug Development Unit, Catalan Institute of Oncology (ICO)(Spain)

Jean-François Martini

Senior Director, Translational Oncology, Global Product Development-Oncology, Pfizer, Inc. (USA)

Ni Ming

Director, Office of Shanghai Anti-cancer and Office of International Affairs, Fudan University Shanghai Cancer Center (China)

Kaitlynn Moser

Senior Vice President, Clinical Operations & Patient Affairs, InterVenn (USA)

Finn Cilius Nielsen

Professor and Head of Centre for Genomic Medicine, Rigshospitalet (Denmark)

Amir Onn

Head of Standard Operating Procedures and Repository Committee, WIN Consortium; Chair, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)

Prithwish Pal

Associate Director, Medical Affairs - Oncology, Illumina (USA)

Jim Palma

Executive Director of TargetCancer Foundation (USA)

Alejandro Piris

Head of the Scientific Management Department, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Angel Porgador

Professor and Dean, Faculty of Health Sciences, Ben-Gurion University of the Negev (Israel)

C.S. Pramesh

Director, Tata Memorial Hospital; Professor and Head, Thoracic Surgery, Division of Surgical Oncology, Tata Memorial Centre (India)

Rui Manuel Reis

Executive and Scientific Director, Research and Education Institute, Coordinator, Molecular Oncology Research Center, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)

Eitan Rubin

Head of Bioinformatics, WIN Consortium; Senior Lecturer, Ben-Gurion University of the Negev (Israel)

Pierre Saintigny

Laboratory of Translational Research, Department of Translational Research and Innovation, Centre Léon Bérard (France)

Ramón Salazar

Head of Medical Oncology Department, Catalan Institute of Oncology (ICO)(Spain)

Marina Sekacheva

Head of the Membership Committee, WIN Consortium; Director of Personalized Oncology Institute, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)

Manju Sengar

Professor, Medical Oncology - Tata Memorial Center (India)

Benjamin M. Solomon

Asst Professor of Medicine, Avera Cancer Institute (USA)

Alan Spatz

Director, Department of Pathology & Professor of Pathology & Oncology, Jewish General Hospital & McGill University (Canada)

Andrey A. Svistunov

First Vice Rector for Innovation and International Affairs, I.M Sechenov First Moscow State Medical University (Russia)

Josep Tabernero

Vice Chairman, WIN Consortium; Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Catalin Vlad

General Manager, The Oncology Institute Ion Chiricuta (IOCN) (Romania)

Casey Williams

Chief Scientific Officer and Executive Director of Cancer Research, Avera Cancer Institute (USA)